Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Change in Receivables (2019 - 2026)

Updated

Korro Bio's Change in Receivables came in at -$969,000 for Q1 2026, compared with $228,000 a year earlier.

Analysis

Korro Bio (KRRO) Change in Receivables (2019 - 2026) Analysis & Trends

For FY2025, Korro Bio's Change in Receivables was -$727,000.

  • Going back by year, Change in Receivables was $1.7 million in FY2024.
  • Business Quant data shows KRRO's Change in Receivables at $149,000 (Q4 2025), -$269,000 (Q3 2025) and -$835,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Korro Bio 281.05 Mn -128.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -969,000.00
Dec 31, 2025 149,000.00
Sep 30, 2025 -269,000.00
Jun 30, 2025 -835,000.00
Mar 31, 2025 228,000.00
Dec 31, 2024 1.70 Mn
Mar 31, 2020 247,000.00
Mar 31, 2019 -112,000.00
API Access

Korro Bio Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=KRRO&period=max&api_key=YOUR_API_KEY